Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum

7Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study evaluated in vitro interactions of antituberculosis drugs and triazoles against Histoplasma capsulatum. Nine drug combinations, each including an antituberculosis drug (isoniazid, pyrazinamide, or ethambutol) plus a triazole (itraconazole, fluconazole, or voriconazole), were tested against both growth forms of H. capsulatum. Stronger synergistic interactions were seen in isoniazid or pyrazinamide plus triazoles for the mold form and ethambutol plus voriconazole for the yeast-like form. Further studies should evaluate these combinations in vivo. Copyright © 2011, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Cordeiro, R. D. A., Marques, F. J. D. F., Brilhante, R. S. N., De Castro E Silva, K. R., Mourão, C. I., Caetano, É. P., … Sidrim, J. J. C. (2011). Synergistic effect of antituberculosis drugs and azoles in vitro against Histoplasma capsulatum var. capsulatum. Antimicrobial Agents and Chemotherapy, 55(9), 4482–4484. https://doi.org/10.1128/AAC.01471-10

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free